Connection

John Wrangle to Melanoma, Experimental

Back to Details
This is a "connection" page, showing publications John Wrangle has written about Melanoma, Experimental.
John Wrangle
Connection Strength
0.296
Melanoma, Experimental
  1. SLC36A1-mTORC1 signaling drives acquired resistance to CDK4/6 inhibitors. Sci Adv. 2019 09; 5(9):eaax6352.
    View in: PubMed
    Score: 0.161
  2. Murine Th17 cells utilize IL-2 receptor gamma chain cytokines but are resistant to cytokine withdrawal-induced apoptosis. Cancer Immunol Immunother. 2017 Jun; 66(6):737-751.
    View in: PubMed
    Score: 0.135
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.